Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SPATA25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MSR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM151A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF644 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCEL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEX3C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
G3BP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UGGT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCONS_00029157 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GAS7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAV2-AS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COMMD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM199X - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC11C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAMA5-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on